I briefly owned SPL along with LCT and AVH up until December 2017. I disposed of all of my holdings in all three companies after I lost my shirt on LCT because of a failed phase 2 trial on a promising drug. My takeaway from that experience was that I would only invest in a pharma startup with either a fully approved game changing product or with game changing pipeline + a revenue generating product. I am just waiting for the big SPL announcement to reevaluate whether I should jump back in.
Here is an opportunity to ask Jackie anything before opening on Friday 13th, page-10
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
-0.005(4.76%) |
Mkt cap ! $41.23M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 10.0¢ | $2.929K | 28.68K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 38470 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 115551 | 4 |
View Market Depth
| Last trade - 13.07pm 12/07/2024 (20 minute delay) ? |
| SPL (ASX) Chart |